CAPTRUST Financial Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,025
| Closed | -$739K | – | 4922 |
|
|
2021
Q2 | $739K | Sell |
4,025
-8,064
| -67% | -$1.48M | 0.01% | 839 |
|
|
2021
Q1 | $1.85M | Sell |
12,089
-21,630
| -64% | -$3.31M | 0.02% | 490 |
|
|
2020
Q4 | $5.27M | Buy |
33,719
+2,571
| +8% | +$402K | 0.07% | 233 |
|
|
2020
Q3 | $3.6M | Buy |
31,148
+4,478
| +17% | +$518K | 0.06% | 253 |
|
|
2020
Q2 | $3M | Buy |
26,670
+24,731
| +1,275% | +$2.78M | 0.05% | 289 |
|
|
2020
Q1 | $174K | Sell |
1,939
-916
| -32% | -$82.2K | ﹤0.01% | 915 |
|
|
2019
Q4 | $308K | Buy |
2,855
+1,970
| +223% | +$213K | ﹤0.01% | 834 |
|
|
2019
Q3 | $87K | Buy |
885
+110
| +14% | +$10.8K | ﹤0.01% | 823 |
|
|
2019
Q2 | $102K | Buy |
775
+64
| +9% | +$8.42K | ﹤0.01% | 759 |
|
|
2019
Q1 | $96K | Buy |
711
+391
| +122% | +$52.8K | ﹤0.01% | 715 |
|
|
2018
Q4 | $31K | Buy |
+320
| New | +$31K | ﹤0.01% | 895 |
|
|
2018
Q2 | – | Sell |
-17
| Closed | -$2K | – | 1645 |
|
|
2018
Q1 | $2K | Buy |
+17
| New | +$2K | ﹤0.01% | 1261 |
|